SJS Investment Consulting »

First Tracks Biotherapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-06-30 $603 30 20.13

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultr Fix Inc Etf (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Eli Lilly & Co. (LLY)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Apple (AAPL)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
American Centy Etf Tr Avan Tota Eq Etf (AVTM)
Dimensional Etf Trust Global Real Est (DFGR)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Us Sustainabilty (DFSU)

View all positions for SJS Investment Consulting

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics